Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients.

Singh, Y; Gupta, G; Anand, K; Kumar Jha, N; Thangavelu, L; Kumar Chellappan, D; Dua, K

Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients.

Singh, Y Gupta, G Anand, K Kumar Jha, N Thangavelu, L Kumar Chellappan, D Dua, K

Permalink

Publication Type:: Journal Article
Citation:: European review for medical and pharmacological sciences, 2021, 25, (2), pp. 580-582
Issue Date:: 2021-01

Recently Added

	Filename	Description	Size
	580-582.pdf	Published Version	715.09 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is new to OPUS and is not currently available.

Full metadata record

Field	Value	Language
dc.contributor.author	Singh, Y
dc.contributor.author	Gupta, G
dc.contributor.author	Anand, K
dc.contributor.author	Kumar Jha, N
dc.contributor.author	Thangavelu, L
dc.contributor.author	Kumar Chellappan, D
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2022-01-05T05:05:44Z
dc.date.available	2022-01-05T05:05:44Z
dc.date.issued	2021-01
dc.identifier.citation	European review for medical and pharmacological sciences, 2021, 25, (2), pp. 580-582
dc.identifier.issn	1128-3602
dc.identifier.issn	2284-0729
dc.identifier.uri	http://hdl.handle.net/10453/152701
dc.format	Print
dc.language	eng
dc.relation.ispartof	European review for medical and pharmacological sciences
dc.relation.isbasedon	10.26355/eurrev_202101_24614
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject.classification	Gastroenterology & Hepatology
dc.subject.mesh	Humans
dc.subject.mesh	Diabetes Mellitus
dc.subject.mesh	Obesity
dc.subject.mesh	Metformin
dc.subject.mesh	Anti-Obesity Agents
dc.subject.mesh	Hypoglycemic Agents
dc.subject.mesh	Drug Therapy, Combination
dc.subject.mesh	Orlistat
dc.subject.mesh	COVID-19
dc.subject.mesh	Anti-Obesity Agents
dc.subject.mesh	COVID-19
dc.subject.mesh	Diabetes Mellitus
dc.subject.mesh	Drug Therapy, Combination
dc.subject.mesh	Humans
dc.subject.mesh	Hypoglycemic Agents
dc.subject.mesh	Metformin
dc.subject.mesh	Obesity
dc.subject.mesh	Orlistat
dc.title	Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients.
dc.type	Journal Article
utslib.citation.volume	25
utslib.location.activity	Italy
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
utslib.copyright.status	recently_added	*
dc.date.updated	2022-01-05T05:05:42Z
pubs.issue	2
pubs.publication-status	Published
pubs.volume	25
utslib.citation.issue	2

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/152701